Body mass index, cardiac surgery and clinical outcome. A single-center experience with 9125 patients

A Zittermann1, T Becker1, J F Gummert1

  • 1Clinic for Thoracic and Cardiovascular Surgery, Heart Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany.

Insights

Both underweight and severely obese patients face higher risks after cardiac surgery. Underweight individuals, in particular, show increased mid-term mortality and complications, requiring special attention.

Area of Science:

  • Cardiology
  • Surgical Outcomes
  • Obesity Research

Background:

  • A J-shaped association between Body Mass Index (BMI) and mortality exists in the general population.
  • The impact of BMI on mortality and major adverse cardiac and cerebrovascular events (MACCE) in cardiac surgery patients remains unclear.

Purpose of the Study:

  • To investigate the effect of BMI on MACCE, intensive care unit (ICU)-related outcomes, and mid-term mortality in cardiac surgical patients.
  • To identify specific BMI categories associated with increased risks in this patient cohort.

Main Methods:

  • Analysis of 9125 consecutive cardiac surgery patients operated on between July 2009 and July 2012.
  • Categorization of patients into underweight, normal BMI, overweight, obese, and severely obese groups.
  • Multivariable analysis to adjust for potential confounders and assess the association between BMI and outcomes.

Main Results:

  • Severely obese patients had a higher odds ratio for MACCE (1.39) compared to overweight patients.
  • Underweight and severely obese patients experienced longer mechanical ventilation and ICU stays.
  • Underweight patients showed a significantly higher adjusted hazard ratio for 2-year mortality (1.72 vs. normal BMI, 2.07 vs. overweight BMI).
  • Red blood cell concentrate requirements were highest in underweight patients.

Conclusions:

  • Both severe obesity and underweight are independent risk factors for operative complications in cardiac surgery.
  • Underweight status poses a significant risk for mid-term survival in patients undergoing cardiac surgery, warranting specific clinical attention.
Abstract